Texan Capital Management’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$2.94M Sell
39,043
-1,842
-5% -$139K 1.91% 15
2017
Q3
$3.15M Sell
40,885
-943
-2% -$71.2K 2.08% 12
2017
Q2
$3.13M Buy
41,828
+17,835
+74% +$1.26M 2.1% 12
2017
Q1
$1.6M Buy
23,993
+104
+0.4% +$6.93K 0.73% 51
2016
Q4
$1.56M Sell
23,889
-5,870
-20% -$381K 0.73% 55
2016
Q3
$2.11M Buy
29,759
+137
+0.5% +$9.98K 0.99% 38
2016
Q2
$2.19M Sell
29,622
-37
-0.1% -$2.56K 1% 31
2016
Q1
$1.93M Buy
29,659
+13,760
+87% +$936K 0.9% 43
2015
Q4
$1.23M Buy
15,899
+224
+1% +$17.8K 0.55% 65
2015
Q3
$1.29M Buy
15,675
+100
+0.6% +$8.9K 0.57% 66
2015
Q2
$1.37M Sell
15,575
-435
-3% -$39.9K 0.55% 69
2015
Q1
$1.42M Sell
16,010
-11,049
-41% -$980K 0.78% 53
2014
Q4
$2.25M Buy
27,059
+756
+3% +$62.7K 0.99% 41
2014
Q3
$2.22M Buy
26,303
+58
+0.2% +$4.69K 0.94% 39
2014
Q2
$2.13M Hold
26,245
0.92% 32
2014
Q1
$2M Buy
26,245
+16,779
+177% +$1.22M 0.92% 31
2013
Q4
$682K Sell
9,466
-6,495
-41% -$451K 0.35% 80
2013
Q3
$1.1M Buy
15,961
+1,808
+13% +$120K 0.53% 59
2013
Q2
$897K Buy
+14,153
New +$921K 0.43% 76

Other funds holding NVS

Texan Capital Management's NVS Position: Q4 2017 in Review

Texan Capital Management reduced its Novartis (NVS) stake by 4.5% in Q4 2017, selling an estimated $139K and leaving 39,043 shares worth $2.94M. The position accounts for 1.91% of the portfolio, ranked #15.

Texan Capital Management first reported a position in NVS in Q2 2013 and has held it in 19 quarters since. The position peaked at $3.15M in Q3 2017. 1,007 funds tracked by Wall St. Rank hold NVS as of Q4 2017.

  • Texan Capital Management held 39,043 shares of Novartis worth $2.94M as of Q4 2017.
  • Texan Capital Management sold 1,842 Novartis shares in Q4 2017, an estimated $139K.
  • Novartis made up 1.91% of Texan Capital Management's portfolio in Q4 2017, its #15 holding.
  • Texan Capital Management first reported a position in Novartis in Q2 2013 and has held it in 19 quarters since.
  • Texan Capital Management's Novartis position peaked at $3.15M in Q3 2017.
  • 1,007 funds tracked by Wall St. Rank held Novartis as of Q4 2017.

Based on Texan Capital Management's 13F filing for Q4 2017, filed 2 Feb 2018.